PRCSG News
NEW - FDA approves subcutaneous formulation of ACTEMRA for systemic JIA - September 2018
Revised Common Rule: educational videos created by OHRP
May 2018 - FDA approves subcutaneous formulation of Actemra for use is Polyarticular Juvenile Idiopathic Arthritis